ArticleChina CDC weekly2023

Uptake of Heterologous or Homologous COVID-19 Booster Dose and Related Adverse Events Among Diabetic Patients: A Multicenter Cross-Sectional Study - China, 2022.

Fan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.